Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…ximity to mediastinal structures, chemotherapy was started with carboplatin and etoposide, leading to improvement in skin and mucosal lesio…
…nclusion, the patient underwent neoadjuvant chemoimmunotherapy (nivolumab, carboplatin and paclitaxel) followed by surgery (right thoraco…
…chemotherapy will receive DC therapy alongside standard-of-care carboplatin/paclitaxel chemotherapy and interval cytoreductive surgery. The…
… with treatment-naïve, stage IV NSQ NSCLC without AGAs received STK-012 subcutaneously (SC) Q3W + standard of care pembrolizumab, pemet…
…ed favorable, with no new safety signals identified.Conclusions Ivonescimab plus chemotherapy demonstrated a clinically meaningful and stat…
…tage III NSCLC who were treated with chemoradiation followed by durvalumab. Data collection included baseline characteristics, treatment p…
… van Laarhoven HWM. Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II…
… of definitive surgery who had received chemotherapy along with Pembrolizumab as neoadjuvant settings. After the definitive surgery the biops…
… 32mos). We discover that after two cycles of chemotherapy with nivolumab long-term responders (PFS>12 months) have a tumor microenvironm…
…ety signals after 9 months of follow-up.All 7 patients received A2B694, were efficacy-evaluable, and had A2B694 detected post-infusion…
…ti-PD-1 or anti-PD-L1 antibodies) plus concurrent chemotherapy (cisplatin or carboplatin) is now part of the standard of care for non-sma…
…ogie Obstétrique) IVB disease, mainly received a combination of carboplatin and paclitaxel (78.0%), while 131 patients receiving second-lin…